[{"data":1,"prerenderedAt":169},["ShallowReactive",2],{"drug-prednisolone-eye":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":35,"contraindications":60,"warnings":70,"renal":78,"monitoring":79,"interactions":80,"review":81,"examples":84,"atc":90,"iran":92,"links":112,"populations":127,"usApproval":164},"prednisolone-eye",1,{"fa":7,"en":8},"قطره پردنیزولون استات ۱٪","Prednisolone acetate 1% eye drops","sensory-organs",{"fa":11,"en":12},"کورتون چشمی","Ophthalmic corticosteroid",[14],{"name":15,"market":16},"Pred Forte","US",[18,19,20,21],"pred forte","پرد فورت","پردنیزولون چشمی","قطره کورتون چشم",[23],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":30,"refs":31},"susp","eye-drops","ophthalmic","1% ophthalmic suspension",{"amount":5,"unit":29,"perUnit":29},"drop",[16],[32],{"source":33,"section":34},"fda-predforte","How Supplied",[36],{"id":37,"disease":38,"label":39,"population":42,"type":46,"unit":29,"dose":47,"refs":50,"notes":53},"infl","ocular-inflammation",{"fa":40,"en":41},"التهاب پاسخ‌ده به کورتون — ۲ قطره چهار بار در روز","Steroid-responsive inflammation — 2 drops four times daily",{"minAge":43},{"value":44,"unit":45},18,"year","fixed",{"perDose":48,"dosesPerDay":49},2,4,[51],{"source":33,"section":52},"Dosage and Administration",[54],{"text":55,"refs":58},{"fa":56,"en":57},"قبل از مصرف تکان دهید. اگر ظرف ۲ روز بهبود نیافت ارزیابی دوباره. ناگهانی قطع نشود.","Shake well. Re-evaluate if no improvement in 2 days. Do not stop prematurely.",[59],{"source":33,"section":52},[61],{"id":62,"severity":63,"text":64,"refs":67},"ci","block",{"fa":65,"en":66},"بیشتر عفونت‌های ویروسی قرنیه و ملتحمه (از جمله هرپس دندریتیک، واریسلا)، عفونت مایکوباکتریایی و قارچی چشم.","Most viral diseases of cornea and conjunctiva (incl. dendritic herpes, varicella), mycobacterial and fungal eye infections.",[68],{"source":33,"section":69},"Contraindications",[71],{"text":72,"refs":75},{"fa":73,"en":74},"مصرف طولانی: افزایش فشار چشم\u002Fگلوکوم و آب مروارید.","Prolonged use: raised intraocular pressure\u002Fglaucoma and cataract.",[76],{"source":33,"section":77},"Warnings",[],[],[],{"status":82,"reviewer":83,"date":83},"unverified",null,[85],{"regimen":37,"formulation":24,"input":86,"expect":89},{"ageYears":87,"weightKg":88},40,70,{"perDose":48},[91],"S01BA04",{"status":93,"forms":94,"refs":107},"registered",[95,99,103],{"code":96,"en":97,"fa":98},"01046","PREDNISOLONE ACETATE 1% OPH DROP","قطره چشمی پردنیزولون استات ۱ درصد",{"code":100,"en":101,"fa":102},"01047","PREDNISOLONE-S 10ML OPH DROP","قطره چشمی پردنیزولون–S ۱۰ میلی‌لیتر",{"code":104,"en":105,"fa":106},"52376","PREDNISOLONE SUSPENSION, DROPS OPHTHALMIC 1 % 5 mL","قطره چشمی پردنیزولون ۱ درصد ۵ میلی‌لیتر",[108],{"source":109,"section":110,"url":111},"darooyab-generic","G-4583\u002FPrednisolone-Ophthalmic","https:\u002F\u002Fwww.darooyab.ir\u002FG-4583\u002FPrednisolone-Ophthalmic",[113,117,121,124],{"kind":114,"url":115,"label":116},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=017469","NDA017469",{"kind":118,"url":119,"label":120},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=3011a244-24a4-46ef-979a-b5d9e7076246","FDA Pred acetate 1% eye",{"kind":122,"url":123,"label":91},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01BA04",{"kind":125,"url":111,"label":126},"darooyab","Prednisolone-Ophthalmic",{"pregnancy":128,"lactation":137,"pediatric":146,"geriatric":155},{"level":129,"text":130,"quote":133,"refs":134},"caution",{"fa":131,"en":132},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","",[135],{"source":33,"section":136},"Pregnancy:",{"level":138,"text":139,"quote":142,"refs":143},"avoid",{"fa":140,"en":141},"برچسب: شیردهی توصیه نمی‌شود یا باید بین دارو و شیردهی یکی انتخاب شود.","Label: breastfeeding not recommended, or choose between the drug and breastfeeding.","Because of the potential for serious adverse reactions in nursing infants from prednisolone acetate, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.",[144],{"source":33,"section":145},"Nursing Mothers:",{"level":147,"text":148,"quote":151,"refs":152},"not-established",{"fa":149,"en":150},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Safety and effectiveness in pediatric patients have not been established.",[153],{"source":33,"section":154},"Pediatric Use:",{"level":156,"text":157,"quote":160,"refs":161},"ok",{"fa":158,"en":159},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety or effectiveness have been observed between elderly and younger patients.",[162],{"source":33,"section":163},"Geriatric Use:",{"kind":165,"refs":166,"id":116},"NDA authorized generic",[167],{"source":33,"section":168},"SPL approval \u002F marketing category",1792092043187]